Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genetic Lingo01:11

Genetic Lingo

84.7K
Overview
84.7K
Pedigree Analysis01:35

Pedigree Analysis

78.8K
Overview
78.8K
Pleiotropy01:33

Pleiotropy

31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis.

Neurology and therapy·2026
Same author

Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Feasibility Study of an Early, Interdisciplinary, Non-Pharmacological Intervention for Patients at Risk of Developing Persistent Post-Traumatic Headache: The PTHEENOT intervention.

Journal of multidisciplinary healthcare·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

[Developing anti-CD20 molecules and B cell depletion in multiple sclerosis].

Ideggyogyaszati szemle·2026
Same author

Differential Progression of Neuroinflammation in Patients with Isolated Rapid-Eye-Movement Sleep Behavior Disorder.

Movement disorders : official journal of the Movement Disorder Society·2026

相关实验视频

Updated: Apr 30, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

多发性硬化症表型过渡的模式和预测因素

Luigi Pontieri1, Nupur Greene2, Malthe Faurschou Wandall-Holm1

  • 1The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital-Rigshospitalet Glostrup, 2600 Glostrup, Denmark.

Brain communications
|December 23, 2024
PubMed
概括

这项研究揭示了预测多发性硬化症进展的因素. 高龄和男性性别增加了过渡到非复发性二级渐进性多发性硬化症的风险,而复发较少和较高的残疾减少了这一风险.

关键词:
多发性硬化症多发性硬化症现实世界的数据数据.登记册研究 登记册研究二次进展性多发性硬化症.

更多相关视频

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

相关实验视频

Last Updated: Apr 30, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

科学领域:

  • 神经学 神经学
  • 临床流行病学 临床流行病学

背景情况:

  • 对于非活跃的次级渐进性多发性硬化症 (SPMS) 存在有限的治疗选择.
  • 了解表型转变对于治疗多发性硬化症至关重要.

研究的目的:

  • 探索复发性复发性多发性硬化 (RRMS),活跃的SPMS和非活跃的SPMS表型之间的转变模式和预测因素.
  • 确定影响从RRMS到SPMS以及SPMS状态之间的进展的因素.

主要方法:

  • 一项使用丹麦多发性硬化病注册表的队列研究.
  • 包括4413名RRMS患者,使用多态马尔科夫模型分析过渡到SPMS.
  • 根据前两年内复发的定义表型.

主要成果:

  • 年龄较大,男性性别较大,复发较少,EDSS较高,DMT使用时间较长预计从RRMS过渡到非复发的SPMS.
  • 没有发现从复发性SPMS过渡到非复发性SPMS的有意义的预测因素.
  • 年龄较大可以防止从非复发性SPMS过渡到复发性SPMS.

结论:

  • 从RRMS过渡到非复发性SPMS受已确定的MS进展因素的影响.
  • 在SPMS表型之间随后的转变主要取决于年龄.
  • 这些发现有助于理解非活跃的SPMS,并突出未满足的治疗需求.